The Bottom Line

Acne conglobata is one of the most severe forms of acne. It causes large, deeply connected nodules and cysts—mostly on the chest, back, and shoulders—that drain fluid and leave significant scars. It affects roughly 1–2 people per 100,000 and is far more common in men. This condition requires prompt treatment with isotretinoin under a dermatologist's care to prevent permanent disfigurement.

What Is Acne Conglobata?

Acne conglobata is a rare and serious form of acne. Unlike the common pimples and blackheads most people are familiar with, acne conglobata produces large nodules and cysts—often bigger than a centimeter—that link together under the skin, forming tunnels (called sinus tracts) that drain pus. It affects mostly young men between the ages of 18 and 30 and carries a high risk of permanent, severe scarring if not treated quickly.

The condition accounts for about 0.5–1% of all acne cases. It can develop on its own or progress from severe regular acne. A strong family history of severe acne is found in 60–70% of patients. In about 10–15% of cases, acne conglobata is part of a broader condition called SAPHO syndrome, which also involves joint and bone inflammation.

Signs and Symptoms

Acne conglobata looks and feels very different from typical acne. Common features include:

  • Large nodules and cysts, often 0.5–2 centimeters or larger, that are deeply painful
  • Interconnected lesions that form underground tunnels (sinus tracts) with ongoing drainage of pus
  • Widespread comedones (blackheads and whiteheads) and smaller pimples surrounding the larger nodules
  • Hardened, scarred skin between lesions
  • Predominantly affects the chest, back, shoulders, and buttocks—areas with the most oil glands

About 40–50% of patients also have systemic (whole-body) symptoms, including fever up to 39–40°C (102–104°F), joint pain (especially in the knees, hips, and lower back), fatigue, and general malaise. The psychological toll is also significant: depression affects 50–60% of patients, and the condition can cause social withdrawal.

What Causes Acne Conglobata?

Acne conglobata develops when several things go wrong at once in the skin and immune system:

  • Severe blockage of multiple hair follicles that then rupture and merge under the skin
  • Excess oil (sebum) production driven by androgens (male hormones)
  • An overactive inflammatory immune response that cannot shut itself off
  • Poor wound healing—the skin breaks down faster than it can repair itself
  • Infection with multiple bacteria, including Cutibacterium acnes and Staphylococcus aureus

Genetics plays a major role, with a strong family history present in most patients. The condition is also associated with two related skin disorders—pilonidal sinus disease and hidradenitis suppurativa—in 20–30% of patients (collectively called the follicular occlusion triad).

Treatment Options

Acne conglobata requires aggressive treatment. Standard over-the-counter acne products will not work. A dermatologist must oversee care.

  • Isotretinoin (Accutane): This is the cornerstone of treatment. Isotretinoin is a powerful oral medication that reduces oil production, shrinks oil glands, and stops the cycle of cyst formation. It achieves complete or near-complete remission in 85–90% of patients. Treatment typically lasts 4–6 months. Because isotretinoin causes severe birth defects, women of childbearing age must use reliable contraception and enroll in the FDA's iPLEDGE program. Regular blood tests to monitor liver enzymes and cholesterol are required.
  • Oral antibiotics: Doxycycline (100 mg twice daily) or minocycline are used as bridge therapy while waiting for isotretinoin to take effect—this usually takes 4–6 weeks. Antibiotics help reduce inflammation and bacterial load.
  • Oral corticosteroids (prednisone): Used short-term to control severe inflammation, especially when lesions are very active or painful. They are tapered off as other medications take effect.
  • Surgical drainage: Large, fluctuant abscesses sometimes need to be drained to relieve pain and speed healing.
  • Scar treatment: After active acne is controlled, procedures such as laser resurfacing, chemical peels, or subcision can improve the appearance of scars.

When to See a Dermatologist

  • You have large, painful, connected nodules or cysts that do not respond to standard acne treatment
  • Your acne is accompanied by fever, joint pain, or fatigue
  • Your acne is leaving significant scars
  • Your acne is spreading rapidly or worsening
  • You have a family history of severe nodular or cystic acne
  • You notice tunneling or draining sinuses under the skin

Frequently Asked Questions

Is acne conglobata the same as regular cystic acne?

No. While both involve cysts, acne conglobata is much more severe. Its defining feature is interconnected lesions that form sinus tracts—tunnels under the skin—and it often causes systemic symptoms like fever and joint pain. Regular cystic acne does not form these interconnections or cause systemic illness.

How long does treatment take?

Active treatment usually takes 4–6 months with isotretinoin. However, the full effect on inflammation and scarring may take 12 months or more. Joint and systemic symptoms often improve within 4–8 weeks of starting treatment.

Will it come back after isotretinoin?

Isotretinoin achieves permanent or very long-term remission in 85–90% of patients. A small percentage may need a second course. Because the condition has a strong genetic component, very early treatment can significantly reduce the risk of permanent disfigurement.

Can acne conglobata cause problems beyond the skin?

Yes. About 10–15% of patients develop SAPHO syndrome, which involves joint inflammation, bone changes, and pustular skin rash in addition to acne conglobata. In 20–30% of patients, acne conglobata is one of three related conditions (along with hidradenitis suppurativa and pilonidal sinus) that occur together due to the same underlying problem with hair follicle occlusion.

References

  1. Karvonen SL. Acne fulminans: report of clinical findings and treatment of twenty-four patients. J Am Acad Dermatol. 1993;28(4):572-579.
  2. Dessinioti C, Katsambas A. Difficult and rare forms of acne. Clin Dermatol. 2017;35(2):138-146.
  3. Sayed CJ, et al. The pathogenesis of hidradenitis suppurativa and the follicular occlusion triad. J Am Acad Dermatol. 2015;73(5 Suppl 1):S27-S32.
  4. Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol. 2001;2(3):135-141.

Trusted Resources

Always consult a board-certified dermatologist for diagnosis and personalized treatment recommendations.